MedShr News

Sickle cell disease (SCD) affects over 400,000 newborns annually, with particularly high mortality rates in low- and middle-income countries (LMICs) such as India and Sub-Saharan Africa (SSA). At this year's American Society of Hematology conference in San Diego, MedShr founder Dr Asif Qasim presents a groundbreaking mobile-first medical education programme and its impact on SCD diagnosis and management in Kenya, Ghana, Zambia, Uganda, Tanzania and India.

Representing a novel approach to HCP engagement and medical education, MedShr secured a Gold and a Silver Award for the “Engaging HCP Communities” category and a Silver for “Healthcare Charities, Patient Associations and the NHS”

June 2023

2 March, 2023

 

MedShr is excited to launch MedShr docsearch, an AI-driven platform that analyses published medical evidence and rapidly reviews complex scientific literature. This technology is being put in the hands of clinicians and academics for the first time, exclusively through MedShr.